FAAP | Jotup

Pediatric Academic Societies Meeting Includes Symposium on Cost-Effectiveness of Implementing Exclusive Human Milk-Based Nutrition for Premature Infants

Retrieved on:

Friday, May 3, 2024

NICU, Hospital, Health, Adolescence, Infant, Length of stay, BMBF, Parenteral nutrition, Patient, VLBW, Hospice and palliative medicine, Child, FAAP, PAS

DUARTE, Calif., May 3, 2024 /PRNewswire/ -- Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, announced today that Dr. Rangasamy Ramanathan, professor of pediatrics division chief, division of neonatal medicine, Los Angeles General Medical Center and PIH Good Samaritan Hospital, will present published data on the financial and clinical benefits of implementing an Exclusive Human Milk Diet (EHMD) for very low birth weight (VLBW) infants during the 2024 Pediatric Academic Societies (PAS) Meeting on Saturday, May 4, 6:30-8 p.m. ET, in Toronto.

Key Points:

PAS connects thousands of leading pediatric researchers, clinicians, and medical educators worldwide to advance scientific discovery and promote innovation in child and adolescent health.
"We saw significant reductions in length of stay and days on parenteral nutrition, which directly translated to substantial cost savings for our NICU."
"We encourage PAS attendees to attend the symposium to learn more about the clinical and financial benefits of EHMD implementation."
Extensive real-world data affirm EHMD adoption enables critical health improvements for premature infants and major cost reductions for hospitals.

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

Retrieved on:

Tuesday, March 19, 2024

Diary, Patient, IND, Adolescence, Pediatrics, Therapy, FAAP, Rett syndrome, Research, Central nervous system, Risk, Webcast, CNS, Ageing, CHU, Safety, AAV, Mutation, Development, MECP2, Disease, Associate, Sleep, Șaeș, Dysrhythmia, FRCP, MTD, Movement, IDMC, VG, Hyperventilation, Principal, Administration, Index, Seizure, CTA, Female, MHRA, Phenotype, ID, Frasier, Pharmaceutical industry

Notably, she has vastly increased interest in social communication and activities at week 35 compared to earlier post-treatment assessments.

Key Points:

Notably, she has vastly increased interest in social communication and activities at week 35 compared to earlier post-treatment assessments.
Dr. Schultz is a board-certified, licensed pediatric neurologist experienced in treating patients with Rett syndrome and leading gene therapy clinical trials.
She brings more than 17 years of clinical experience and will lead the Company’s clinical development, clinical operations, medical affairs and safety activities.
ET to review its financial and operating results and to provide corporate and clinical updates.

Blessings in a Backpack, Jim & Tabitha Furyk Foundation and Nemours Children’s Health Raise Awareness of Childhood Food Insecurity at THE PLAYERS Championship

Retrieved on:

Friday, March 15, 2024

On Wednesday, March 12, the Jim & Tabitha Furyk Foundation and Nemours Children’s Health joined Blessings in a Backpack at THE PLAYERS Championship Kid Zone for the second consecutive year to address childhood hunger in the community.

Key Points:

On Wednesday, March 12, the Jim & Tabitha Furyk Foundation and Nemours Children’s Health joined Blessings in a Backpack at THE PLAYERS Championship Kid Zone for the second consecutive year to address childhood hunger in the community.
View the full release here: https://www.businesswire.com/news/home/20240315917128/en/
On Wednesday, March 12, the Jim & Tabitha Furyk Foundation and Nemours Children’s Health joined Blessings in a Backpack at THE PLAYERS Championship Kid Zone for the second consecutive year to address childhood hunger in the community.
The organizations packed bags of food for Blessings in a Backpack recipients.
Students also had the opportunity to collect autographs from their favorite golfers at the Autograph Zone, presented by Nemours Children’s Health.

CUTTING-EDGE RESEARCH SHAPING CHILDREN'S HEALTH SHOWCASED AT THE PEDIATRIC ACADEMIC SOCIETIES 2024 MEETING

Retrieved on:

Thursday, April 4, 2024

TORONTO, April 4, 2024 /PRNewswire/ -- Pediatric Academic Societies (PAS) Meeting connects thousands of leading pediatric researchers and other healthcare providers worldwide united by a common mission: Connecting the global academic pediatric community to advance scientific discovery and promote innovation in child and adolescent health.

Key Points:

TORONTO, April 4, 2024 /PRNewswire/ -- Pediatric Academic Societies (PAS) Meeting connects thousands of leading pediatric researchers and other healthcare providers worldwide united by a common mission: Connecting the global academic pediatric community to advance scientific discovery and promote innovation in child and adolescent health.
Research on Neonatology, artificial intelligence, adolescent obesity, mental health, infectious diseases, and other health issues will be featured at the Pediatric Academic Societies (PAS) 2024 Meeting
This unique meeting represents over 70 pediatric specialties and includes more than 350+ sessions, 687 oral abstracts, and 3,300+ posters on general and specialty pediatric health topics, as well as nine Friday pre-conference programs featuring topics on pediatric bioethics, perinatal stroke, kidney health, and more.
Attendees can access sessions, posters, and more through the online program guide and the PAS Meeting mobile app.
"This is the premier forum for pediatric researchers and providers to share the latest research on global and public health issues," Judith Shaw, PAS program chair.

ResBiotic Appoints Stefany Nieto as VP of Operations and Brittany Zenner as Director of Marketing: Elevating Wellness Beyond Boundaries

Retrieved on:

Thursday, March 28, 2024

Health, Biotechnology, Amazon, Science, Medicine, Shark Tank, CPG, Marketing, Walmart, FAAP, Dragon, Physician, Management

BIRMINGHAM, Ala., March 28, 2024 /PRNewswire/ -- ResBiotic Nutrition, Inc. (ResBiotic), the pioneering physician-developed pre/probiotic wellness scale-up, proudly announces the appointments of Stefany Nieto as Vice President of Operations and Brittany Zenner as Director of Marketing. Nieto is a seasoned CPG entrepreneur with a proven track record of building international ventures with enduring social impact, Nieto brings a wealth of experience and a passion for holistic well-being to ResBiotic. Zenner is an accomplished brand marketer at the intersection of wellness, science, and CPG, with almost a decade of experience driving growth and customer retention for startups in the better-for-you space.

Key Points:

Zenner is an accomplished brand marketer at the intersection of wellness, science, and CPG, with almost a decade of experience driving growth and customer retention for startups in the better-for-you space.
In her new role at Resbiotic, Nieto will helm all day-to-day business operations, wholesale expansion, and a roadmap for the brand's hyper-growth while also leading the team in new product development.
"Appointing Stefany as our Vice President of Operations and Brittany as our Director of Marketing marks a pivotal moment in our journey towards redefining wellness," stated C. Vivek Lal, MD, FAAP, Founder & CEO of ResBiotic.
In her previous roles, Nieto co-founded Gwella and Mojo Microdose, successful ventures specializing in functional mushroom supplement gummies that enhance modern wellness.

Plagiocephaly and Torticollis Awareness Month

Retrieved on:

Wednesday, March 27, 2024

Parent, Osteopathy, SAN, Colic, Plagiocephaly, Torticollis, FAAP, OMT

SAN DIEGO, March 27, 2024 /PRNewswire/ -- The Osteopathic Center for Children & Osteopathy's Promise to Children is now looking for infants 4 months old and younger diagnosed with plagiocephaly (flat head syndrome), which affects 47% of infants in the US. If left untreated, this can cause vision problems, muscular tightness, dental issues, & developmental delays. Qualified infants who enroll in this study will receive gentle, hands-on treatment known as Osteopathic Manipulative Treatment (OMT), which has been proven to address the underlying cause of plagiocephaly, reducing its impact on the child's development more than current treatments, such as helmet therapy.

Key Points:

New Study Offering Free Plagiocephaly Treatment (an alternative to helmet therapy) in San Diego, California!
SAN DIEGO, March 27, 2024 /PRNewswire/ -- The Osteopathic Center for Children & Osteopathy's Promise to Children is now looking for infants 4 months old and younger diagnosed with plagiocephaly (flat head syndrome), which affects 47% of infants in the US .
If left untreated, this can cause vision problems, muscular tightness, dental issues, & developmental delays.
"We use OMT to evaluate & treat the whole body, not just one area of concern.

UCI Health celebrates transformational acquisition of four community hospitals

Retrieved on:

Wednesday, March 27, 2024

ORANGE, Calif., March 27, 2024 /PRNewswire/ -- UCI Health, the clinical enterprise of the University of California, Irvine, has completed the acquisition of four hospitals and associated outpatient locations from Tenet Healthcare Corporation. Beginning today, the team members at Fountain Valley Regional Hospital, Lakewood Regional Medical Center Los Alamitos Medical Center and Placentia-Linda Hospital are now part of UCI Health.

Key Points:

We celebrate the transformation of UCI Health as a leader in the integration of academic and community-based health systems while promoting solutions to challenges facing healthcare," said UC Irvine Chancellor Howard Gillman.
As Orange County's only academic health system, UCI Health plays a unique and critical role providing healthcare in the region.
"UCI Health has built a legacy as a nationally regarded academic health system that is fiercely dedicated to improving the health of our communities.
Lefteris said UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by these hospitals.

MGMA and Jackson Physician Search Extend Partnership to Enhance Physician Recruitment and Retention for Medical Practices

Retrieved on:

Wednesday, March 27, 2024

Partnership, MMM, FACMPE, Employment, Culture, Physician, FAAP, Nursing

ENGLEWOOD, Colo. and ATLANTA , March 27, 2024 /PRNewswire/ -- The Medical Group Management Association (MGMA) today announced an extended executive partnership with Jackson Physician Search , a national leader in the permanent recruitment of physicians, physician executives and advanced practice providers.

Key Points:

ENGLEWOOD, Colo. and ATLANTA , March 27, 2024 /PRNewswire/ -- The Medical Group Management Association (MGMA) today announced an extended executive partnership with Jackson Physician Search , a national leader in the permanent recruitment of physicians, physician executives and advanced practice providers.
The partnership, which is in its fifth consecutive year, connects MGMA members and medical practices with consultative resources and recruitment solutions that help drive operational efficiencies and improve patient access to care.
MGMA is the nation's largest association focused on the business of medical practice management, consisting of 15,000 group medical practices representing more than 350,000 physicians.
Jackson Physician Search's ongoing collaboration with MGMA continues to enhance the recruitment process for medical groups, connecting association members with best-in-class medical professionals and resources to help navigate the competitive landscape.

Industry Thought Leadership on Display at HIMSS24 Global Conference

Retrieved on:

Monday, March 11, 2024

Automation, Conference, Health, Innovation, Revenue cycle management, RCM, HIMSS, MPH, FAAP, Exhibition, Becker, Emerging market, Pharmaceutical industry

ORLANDO, Fla., March 11, 2024 /PRNewswire/ -- FinThrive, Inc., a leading provider of healthcare revenue cycle management software solutions, announces participation in HIMSS24, the healthcare industry's premier event. Attendees can visit Booth #4851, where FinThrive will unveil its latest solutions, complemented by a live C-suite focused podcast, an education session to foster conversations with healthcare professionals, and in-booth demos and discussions.

Key Points:

This data-driven framework is helping healthcare finance leaders benchmark and build strategic roadmaps to optimize and modernize their technology investments.
Becker and Clawson will share how RCMTAM is helping to shape transformative revenue cycle management strategies to improve financial performance.
Craig Joseph, MD, FAAP, FAMIA, Chief Medical Officer, Nordic Global, discussing where health IT is going beyond 2024, starting with the human connection.
To discover more about FinThrive Analyze and other solutions within the FinThrive end-to-end Revenue Cycle Management platform, visit Booth #4851 at the HIMSS24 Global Health Conference & Exhibition, March 11-15 in Orlando, Fla.
For more information about FinThrive, visit https://finthrive.com .

SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024

Retrieved on:

Monday, March 11, 2024

Chronic kidney disease, FAAP, Multiple organ dysfunction syndrome, Medical director, Critical care, FDA, CKRT, SCD, Hospital, Risk, Conference, University, SeaStar, Acute kidney injury, AKI, CRRT, Nephrology, Pharmaceutical industry

DENVER, March 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces its sponsorship of an Industry Symposium titled “New Therapies in Pediatric Acute Kidney Injury” on March 13, 2024 at the 29th International Conference on Advances in Critical Care Nephrology – Updates in ICU Medicine: Controversies, Challenges and Solutions (AKI & CRRT 2024). The hybrid in-person and virtual conference is being held March 12-15 in San Diego.

Key Points:

The hybrid in-person and virtual conference is being held March 12-15 in San Diego.
“Despite advancements in kidney replacement therapy, mortality rates in children with acute kidney injury (AKI) and multi-organ failure requiring continuous kidney replacement therapy (CKRT) remain at about 50%, and children who survive an AKI episode are at elevated risk of chronic kidney disease.
“It’s exciting to have recognized leaders in AKI and nephrology who serve on the SeaStar Medical Scientific Advisory Board participate in this symposium.
The discussion will highlight our technology, clinical data and the recent FDA approval of the SCD-PED, the first therapeutic device in our Quelimmune product family,” said Kevin Chung, MD, SeaStar Medical’s Chief Medical Officer.